Down-regulation of LATS kinases alters p53 to promote cell migration

Authors:

Abstract
P53 is a pivotal tumor suppressor and a major barrier against cancer. We now report that silencing of the Hippo pathway tumor suppressors LATS1 and LATS2 in nontransformed mammary epithelial cells reduces p53 phosphorylation and increases its association with the p52 NF-κB subunit. Moreover, it partly shifts p53's conformation and transcriptional output toward a state resembling cancer-associated p53 mutants and endows p53 with the ability to promote cell migration. Notably, LATS1 and LATS2 are frequently down-regulated in breast cancer; we propose that such down-regulation might benefit cancer by converting p53 from a tumor suppressor into a tumor facilitator.
Funding Information
  • Center of Excellence Grant (1779/11)
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • Robert Bosch Stiftung
  • Estate of John Hunter
  • Cancer Research at the Weizmann Institute
  • Leir Charitable Foundation
  • German Research Foundation
  • Israel Cancer Research Fund

This publication has 42 references indexed in Scilit: